ScoreWhy is Windlas Biotech Ltd ?
1
Poor long term growth as Operating profit has grown by an annual rate 12.14% of over the last 5 years
2
Flat results in Mar 26
- ROCE(HY) Lowest at 14.90%
- CASH AND CASH EQUIVALENTS(HY) Lowest at Rs 1.81 cr
3
Stock is technically in a Mildly Bearish range
- A key technical factor - Bollinger Band has been Bearish since 19 May 2026
4
Underperformed the market in the last 1 year
- Even though the market (BSE500) has generated returns of 0.10% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -14.58% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Windlas Biotech for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Windlas Biotech
-10.31%
-0.44
33.24%
Sensex
-5.08%
-0.49
12.94%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
16.15%
EBIT Growth (5y)
12.14%
EBIT to Interest (avg)
32.88
Debt to EBITDA (avg)
0.16
Net Debt to Equity (avg)
-0.40
Sales to Capital Employed (avg)
1.33
Tax Ratio
23.59%
Dividend Payout Ratio
19.93%
Pledged Shares
0
Institutional Holding
11.19%
ROCE (avg)
21.76%
ROE (avg)
11.33%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
25
Industry P/E
34
Price to Book Value
2.92
EV to EBIT
19.71
EV to EBITDA
13.93
EV to Capital Employed
4.22
EV to Sales
1.61
PEG Ratio
2.47
Dividend Yield
0.72%
ROCE (Latest)
21.40%
ROE (Latest)
11.44%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Bearish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
NET SALES(Q)
Highest at Rs 238.50 cr
-3What is not working for the Company
ROCE(HY)
Lowest at 14.90%
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 1.81 cr
Loading Valuation Snapshot...
Here's what is working for Windlas Biotech
Net Sales - Quarterly
Highest at Rs 238.50 cr and Grown
each quarter in the last five quartersMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Here's what is not working for Windlas Biotech
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 1.81 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
